[DNLI] YoY Quarter Result on 30-Jun-2024 [#Q2]

Stock
[DNLI] Denali Therapeutics Inc.
Announcement Date
01-Aug-2024
Financial Year
2024
Quarter
30-Jun-2024 [#Q2]
Profit Trend
QoQ- 2.73%
YoY- -154.00%
Quarter Report
DNLI's Result
DNLI's Financial Summary
View:
Show?
Quarter Result
30/06/24 30/06/23 30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 CAGR
Revenue 0 294,123 52,480 22,939 5,847 4,197 1,648 -
PBT -99,026 183,383 -58,767 -60,691 -58,679 -58,650 -54,724 10.37%
Tax 0 -2,285 27 728 79 -313 0 -
NP -99,026 183,383 -58,794 -60,691 -58,758 -58,337 -54,724 10.37%
Tax Rate - 1.25% - - - - - -
Total Cost 99,026 110,740 111,274 83,630 64,605 62,534 56,372 9.83%
Ratio Analysis
30/06/24 30/06/23 30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 CAGR
NP Margin 0.00 62.35 -112.03 -264.58 -1,004.93 -1,389.97 -3,320.63 -
Per Share
30/06/24 30/06/23 30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 CAGR
EPS -0.59 1.34 -0.48 -0.50 -0.56 -0.61 -0.59 0.00%
EPS Diluted -0.59 1.30 -0.48 -0.49 -0.56 -0.61 -0.59 0.00%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.